Idioma:

Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanoma

MORTON, DONALD L. ; HOON, DAVE S. B. ; NIZZE, J. ANNE ; FOSHAG, LELAND J. ; FAMATIGA, ESTELA ; WANEK, LESLIE A. ; CHANG, CINDY ; IRIE, REIKO F. ; GUPTA, RISHAB K. ; ELASHOFF, ROBERT

Annals of the New York Academy of Sciences, 1993-01, Vol.690 (1), p.120-134 [Periódico revisado por pares]

Sem texto completo

Citações Citado por

Título:
Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanoma
Autor: MORTON, DONALD L. ; HOON, DAVE S. B. ; NIZZE, J. ANNE ; FOSHAG, LELAND J. ; FAMATIGA, ESTELA ; WANEK, LESLIE A. ; CHANG, CINDY ; IRIE, REIKO F. ; GUPTA, RISHAB K. ; ELASHOFF, ROBERT
Assuntos: Antibodies, Neoplasm - biosynthesis ; Antigens, Neoplasm - immunology ; Cross Reactions ; Gangliosides - immunology ; Humans ; Hypersensitivity, Delayed - immunology ; Immunotherapy, Active ; Melanoma - therapy ; Neoplasm Metastasis ; Survival Analysis
É parte de: Annals of the New York Academy of Sciences, 1993-01, Vol.690 (1), p.120-134
Notas: istex:6EE7A747C677E5FCC9513171AFCCD2251EBD92DF
ark:/67375/WNG-6NVTGV53-T
This work was supported by grants (CA 12582 and CA 29605) from the National Cancer Institute, DHHS, the Joyce and Ben Eisenberg Foundation, and the Steele Foundation. These investigations were conducted with permission of Human Subjects Protection Committees, the John Wayne Cancer Institute and Saint John's Hospital and Health Care Center, and of the Jonsson Comprehensive Cancer Center.
ArticleID:NYAS120
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Editor: Oxford, UK: Blackwell Publishing Ltd
Idioma: Inglês

Links

Voltar para lista de resultados